We are currently making improvements to the Audible site. In an effort to enhance the accessibility experience for our customers, we have created a page to more easily navigate the new experience, available at the web address www.audible.co.uk/access.
HBR Periodical

HBR: Can Science be a Business? Lessons from Biotech

Regular Price:£1.07
  • Membership Details:
    • First book free with 30-day trial
    • £7.99/month thereafter for your choice of 1 new book each month
    • Cancel easily anytime
    • Exchange books you don't like
    • All selected books are yours to keep, even if you cancel
  • - or -

Publisher's Summary

In 1976, Genentech, the first biotechnology company, was founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche of new drugs has hit the market, and the long-awaited breakthrough in R&D productivity has yet to materialize. This disappointing performance raises a question: Can organizations motivated by the need to make profits and please shareholders successfully conduct basic scientific research as a core activity?

From the October 2006 issue of Harvard Business Review.

Want more Harvard Business Review?
Subscribe for one month or 12 months.
Get the latest issue.
Check out the complete archive.

©2006 by the President and Fellows of Harvard College, All Rights Reserved; (P)2006 Audible Inc.

What Members Say

Average Customer Rating

5.0 (1 )
5 star
 (1)
4 star
 (0)
3 star
 (0)
2 star
 (0)
1 star
 (0)
Overall
5.0 (1 )
5 star
 (1)
4 star
 (0)
3 star
 (0)
2 star
 (0)
1 star
 (0)
Story
5.0 (1 )
5 star
 (1)
4 star
 (0)
3 star
 (0)
2 star
 (0)
1 star
 (0)
Performance
Sort by:
  •  
    Ariel United Kingdom 12/04/2016
    Ariel United Kingdom 12/04/2016 Member Since 2013
    ratings
    REVIEWS
    23
    11
    Overall
    Performance
    Story
    "Informative"

    This seemed to a non expert expert a thorough review of biotech's industry present state.

    0 of 0 people found this review helpful

Report Inappropriate Content

If you find this review inappropriate and think it should be removed from our site, let us know. This report will be reviewed by Audible and we will take appropriate action.

Cancel

Thank you.

Your report has been received. It will be reviewed by Audible and we will take appropriate action.